TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $73,528 | -34.9% | 8,945 | -39.0% | 0.01% | -28.6% |
| Q1 2024 | $112,967 | +44.6% | 14,652 | +68.6% | 0.01% | -6.7% |
| Q4 2023 | $78,123 | +355.8% | 8,690 | +353.3% | 0.02% | +200.0% |
| Q3 2023 | $17,138 | +14.1% | 1,917 | +96.0% | 0.01% | 0.0% |
| Q2 2023 | $15,022 | -23.8% | 978 | +11.5% | 0.01% | -28.6% |
| Q1 2023 | $19,724 | +43.8% | 877 | +34.5% | 0.01% | +16.7% |
| Q4 2022 | $13,712 | -8.6% | 652 | +8.8% | 0.01% | 0.0% |
| Q3 2022 | $15,000 | – | 599 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,026,300 | $21,583 | 6.98% |
| Deep Track Capital, LP | 4,582,000 | $96,359,460 | 4.05% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 379,019 | $7,963,189 | 2.46% |
| ARMISTICE CAPITAL, LLC | 6,412,000 | $134,844,360 | 2.35% |
| GREAT POINT PARTNERS LLC | 475,000 | $9,989,250 | 1.96% |
| RA Capital Management | 3,984,681 | $83,797,841 | 1.70% |
| MPM BioImpact LLC | 281,711 | $5,924,382 | 1.54% |
| HighVista Strategies LLC | 121,834 | $2,562,169 | 1.52% |
| Kynam Capital Management, LP | 418,099 | $8,792,622 | 1.35% |
| SECTORAL ASSET MANAGEMENT INC | 292,320 | $6,147,490 | 1.19% |